Phaarmasia Ltd

Phaarmasia Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Phaarmasia Ltd

₹ 79.5 0.00%
02 Jun - close price
phaarmasia.in BSE: 523620
About

Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets

Key Points

Business Overview:[1][2]
Company provides various therapeutic dosage combinations for Ministry of Health & Family Welfare and also for exports. In FY20, company became a Sick Industrial Company under SICA and was referred to BIFR.

Website BSE
  • Market Cap ₹ 54.3 Cr.
  • Current Price ₹ 79.5
  • High / Low ₹ 132 / 26.0
  • Stock P/E 27.6
  • Book Value ₹ 32.4
  • Dividend Yield 0.00 %
  • ROCE 16.4 %
  • ROE 12.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 44.8% CAGR over last 5 years
  • Debtor days have improved from 60.8 to 39.7 days.

Cons

  • Company has a low return on equity of -0.39% over last 3 years.
  • Earnings include an other income of Rs.20.0 Cr.
  • Working capital days have increased from -17.3 days to 62.1 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
7.50 6.88 8.64 5.08 9.99 8.29 5.93 4.72 5.43 6.87 16.55 16.05 7.73
7.71 7.19 8.91 5.65 9.66 8.11 6.72 5.51 6.04 6.78 14.94 15.21 8.39
Operating Profit -0.21 -0.31 -0.27 -0.57 0.33 0.18 -0.79 -0.79 -0.61 0.09 1.61 0.84 -0.66
OPM % -2.80% -4.51% -3.12% -11.22% 3.30% 2.17% -13.32% -16.74% -11.23% 1.31% 9.73% 5.23% -8.54%
0.14 0.14 0.20 0.13 0.19 0.15 0.22 0.19 0.18 0.32 0.14 19.16 0.34
Interest 0.03 0.01 0.01 0.02 0.00 0.00 0.00 0.01 0.00 0.03 0.00 0.02 0.18
Depreciation 0.17 0.09 0.09 0.08 0.09 0.08 0.08 0.08 0.08 0.06 0.05 0.06 0.04
Profit before tax -0.27 -0.27 -0.17 -0.54 0.43 0.25 -0.65 -0.69 -0.51 0.32 1.70 19.92 -0.54
Tax % -66.67% 0.00% -5.88% 3.70% -9.30% -12.00% 0.00% 1.45% 1.96% 12.50% -2.35% 18.27% 31.48%
-0.09 -0.27 -0.16 -0.56 0.47 0.28 -0.64 -0.70 -0.53 0.27 1.74 16.27 -0.70
EPS in Rs -0.13 -0.40 -0.23 -0.82 0.69 0.41 -0.94 -1.03 -0.78 0.40 2.55 23.83 -1.03
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
12 14 14 19 24 20 16 17 27 31 24 47
11 13 14 18 23 19 16 19 29 31 26 45
Operating Profit 1 1 0 1 1 1 -0 -2 -2 -1 -2 2
OPM % 8% 5% 1% 3% 3% 4% -0% -10% -6% -3% -8% 4%
0 0 1 1 1 1 1 0 1 1 1 20
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 1 1 1 0 -2 -1 -1 -2 21
Tax % 39% 83% 37% 16% 6% 45% 33% -1% -12% -6% -1% 18%
0 0 0 1 1 1 0 -2 -1 -1 -2 18
EPS in Rs 0.21 0.06 0.23 0.83 1.14 0.79 0.45 -2.27 -1.85 -0.76 -2.33 25.74
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 24%
3 Years: 20%
TTM: 94%
Compounded Profit Growth
10 Years: 48%
5 Years: 45%
3 Years: 53%
TTM: 224%
Stock Price CAGR
10 Years: 10%
5 Years: 19%
3 Years: 49%
1 Year: 193%
Return on Equity
10 Years: -1%
5 Years: -5%
3 Years: 0%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 6 5 5 5 6 7 7 5 4 3 2 15
0 0 0 0 0 0 0 0 0 0 0 1
6 7 8 10 20 20 8 9 17 21 13 7
Total Liabilities 19 19 20 22 33 34 22 21 28 31 22 30
16 14 14 14 14 13 13 13 13 12 12 1
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
4 5 6 8 19 20 9 8 16 19 9 29
Total Assets 19 19 20 22 33 34 22 21 28 31 22 30

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 0 -0 1 0 0 0 -0 1 0 0
-0 -0 -0 -1 -0 0 0 0 -0 0 -0
0 0 -0 0 0 -0 -0 0 -0 -0 -0
Net Cash Flow 0 0 -0 0 0 -0 0 -0 0 -0 -0
Free Cash Flow 0 0 -0 -0 -0 0 0 -0 1 0 -0
CFO/OP 59% 68% 21% 153% 32% 41% -817% 1% -42% -13% 0%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 48 78 91 73 179 226 96 69 100 96 47 40
Inventory Days 80 12 56 43 135 125 66 112 103 126 57 48
Days Payable 185 216 293 249 403 374 166 214 269 298 224 23
Cash Conversion Cycle -56 -127 -146 -133 -89 -24 -4 -33 -65 -76 -120 64
Working Capital Days -79 -64 -43 -34 -13 7 8 -17 -39 -43 -71 62
ROCE % 3% 2% 2% 6% 7% 8% 4% -12% -12% -5% -16% 16%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue from Oral Contraceptive Pills (OCP) Sales
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Annual Manufacturing Capacity
Million Units
Number of Permanent Employees
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51%
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.42% 26.44% 26.44% 26.43%
No. of Shareholders 20,77920,72220,68820,68220,64220,59620,61220,62020,51220,49720,40420,301

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports